The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Involvement of MINK, a Ste20 Family Kinase, in Ras Oncogene-Induced Growth Arrest in Human Ovarian Surface Epithelial Cells
Open accessAbstract
The ability of activated Ras to induce growth arrest of human ovarian surface epithelial (HOSE) cells via induction of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) has been used to screen for Ras pathway signaling components using a library of RNA interference (RNAi) vectors targeting the kinome. Two known Ras-regulated kinases were identified, phosphoinositide 3-kinase p110alpha and ribosomal protein S6 kinase p70(S6K1), plus the MAP kinase kinase kinase kinase MINK, which had not previously been implicated in Ras signaling. MINK is activated after Ras induction via a mechanism involving reactive oxygen species and mediates stimulation of the stress-activated protein kinase p38 MAPK downstream of the Raf/ERK pathway. p38 MAPK activation is essential for Ras-induced p21(WAF1/CIP1) upregulation and cell cycle arrest. MINK is thus a distal target of Ras signaling in the induction of a growth-arrested, senescent-like phenotype that may act to oppose oncogenic transformation in HOSE cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ras-induced senescence can be inhibited by using antioxidants or growing cells in low-oxygen conditions (8, 25, 33, 51).”
From Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence (2009) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 4×
“It therefore appears that inducible expression of Ras leads to a growth arrest in this ovarian epithelial cell system by a mechanism that does not involve either p53 or p16, the two pathways most commonly associated with oncogene-induced growth arrest (Lloyd et al., 1997; Serrano et al., 1997; Sewing et al., 1997).”
BackgroundInfluentialTargeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc969 · Cited by 3,354
Self-citationSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 2×
“…the PI 3-kinase inhibitor LY294002 has previously been reported to block hydrogen peroxide-induced senescence in human diploid fibroblasts (Wang et al., 2004) and PTEN deletion has recently been associated with induction of p53-dependent senescence in mouse prostate glands (Chen et al., 2005).”
BackgroundCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Self-citationMitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts
Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T., & Goldschmidt-Clermont, P. J. (1997) · Science · doi:10.1126/science.275.5306.1649 · Cited by 1,588
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Lowe, S. W., Cepero, E., & Evan, G. I. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,374
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
“, 2006), and occurs in a variety of cell types (Lloyd et al., 1997; Nicke et al., 2005; Denoyelle et al., 2006).”
BackgroundThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Lee, S., Rauch, J., & Kölch, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031102 · Cited by 823
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Coelho, M. A., de Carné Trécesson, S., Rana, S., Zecchin, D., Moore, C., Molina-Arcas, M., East, P., Spencer-Dene, B., Nye, E., Barnouin, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.016 · Cited by 653
Self-citationElgendy, M., Sheridan, C., Brumatti, G., & Martin, S. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.009 · Cited by 426
Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence
Moiseeva, O., Bourdeau, V., Roux, A., Deschênes-Simard, X., & Ferbeyre, G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01868-08 · Cited by 408
p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis
Dolado, I., Swat, A., Ajenjo, N., Vita, G. D., Cuadrado, A., & Nebreda, Á. R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.013 · Cited by 422
High-throughput RNAi screening in cultured cells: a user's guide
Echeverri, C. J., & Perrimon, N. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1836 · Cited by 380
Healing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326
Lu, T., & Finkel, T. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.011 · Cited by 327
Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
Xu, Y., Li, N., Xiang, R., & Sun, P. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.04.004 · Cited by 282
Weyemi, U., Lagente-Chevallier, O., Boufraqech, M., Prenois, F., Courtin, F., Caillou, B., Talbot, M., Dardalhon, M., Al Ghuzlan, A., Bidart, J.-M., et al. (2012) · Oncogene · doi:10.1038/onc.2011.327 · Cited by 285
BRAFE600 in benign and malignant human tumours
Michaloglou, C., Vredeveld, L. C. W., Mooi, W. J., & Peeper, D. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210704 · Cited by 278
The pathways to tumor suppression via route p38
Han, J., & Sun, P. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.06.007 · Cited by 274
Reactive oxygen species: A double-edged sword in oncogenesis
Pan, J., Hong, M., & Ren, J. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1702 · Cited by 228
p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance
Grossi, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9744 · Cited by 215
Inflammatory signaling and cellular senescence
Ren, J., Pan, J., Lu, Y.-P., Sun, P., & Han, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 153
RASSF6 is a novel member of the RASSF family of tumor suppressors
Allen, N. P. C., Donninger, H., Vos, M. D., Eckfeld, K., Hesson, L. B., Gordon, L. E., Birrer, M. J., Latif, F., & Clark, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210440 · Cited by 142
shRNA libraries and their use in cancer genetics
Bernards, R., Brummelkamp, T. R., & Beijersbergen, R. L. (2006) · Nature Methods · doi:10.1038/nmeth921 · Cited by 140
Self-citationA kinase shRNA screen links LATS2 and the pRB tumor suppressorPreprint
Tschöp, K., Conery, A. R., Litovchick, L., DeCaprio, J. A., Settleman, J. E., Harlow, E., & Dyson, N. J. (2011) · Genes & Development · doi:10.1101/gad.2000211 · Cited by 129
Alternative splicing of SYK regulates mitosis and cell survival
Prinos, P., Garneau, D., Lucier, J., Gendron, D., Couture, S., Boivin, M., Brosseau, J., Lapointe, E., Thibault, P., Durand, M., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2040 · Cited by 115
Oncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116
Reactive Oxygen Species in Autoimmune Cells: Function, Differentiation, and Metabolism
Lin, W., Shen, P., Song, Y., Huang, Y., & Tu, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635021 · Cited by 105
Mapping effector genes at lupus GWAS loci using promoter Capture-C in follicular helper T cells
Su, C., Johnson, M. E., Torres, A., Thomas, R. M., Manduchi, E., Sharma, P. K., Mehra, P., Coz, C. L., Leonard, M. E., Lu, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17089-5 · Cited by 86
p38α and p38γ Mediate Oncogenic ras-induced Senescence through Differential Mechanisms
Kwong, J., Hong, L., Liao, R., Deng, Q., Han, J., & Sun, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808327200 · Cited by 85
Hyodo, T., Ito, S., Hasegawa, H., Asano, E., Maeda, M., Urano, T., Takahashi, M., Hamaguchi, M., & Senga, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372342 · Cited by 81
Ras regulation of DNA-methylation and cancer
Patra, S. K. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.012 · Cited by 82
Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1
Fu, G., Xu, Q., Qiu, Y., Jin, X., Xu, T., Dong, S., Wang, J., Ke, Y., Hu, H., Cao, X., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161120 · Cited by 65
The p38‐activated ER stress‐ATF6α axis mediates cellular senescence
Kim, H. S., Kim, Y.-J., Lim, M. J., Park, Y.-G., Park, S. I., & Sohn, J. (2018) · The FASEB Journal · doi:10.1096/fj.201800836r · Cited by 65
Smad inhibition by the Ste20 kinase Misshapen
Kaneko, S., Chen, X., Lu, P., Yao, X., Wright, T. G., Rajurkar, M., Kariya, K., Mao, J., Ip, Y. T., & Xu, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104128108 · Cited by 60
Kimura, J., Nguyen, S. T., Liu, H., Taira, N., Miki, Y., & Yoshida, K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn506 · Cited by 58
Chromosomal instability and transcriptome dynamics in cancer
Stevens, J. B., Horne, S. D., Abdallah, B. Y., Ye, C. J., & Heng, H. H. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9428-6 · Cited by 51
LIN, Z.-H., Wang, L., Zhang, J., Liu, Y., Li, X., Guo, L., ZHANG, B., Zhu, W., & Ye, Q. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2455 · Cited by 49
Zheng, H., Seit‐Nebi, A. S., Han, X., Aslanian, A., Tat, J., Liao, R., Yates, J. R., & Sun, P. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.013 · Cited by 50
ZRF1 is a novel S6 kinase substrate that drives the senescence programme
Barilari, M., Bonfils, G., Treins, C., Koka, V., Villeneuve, D. D., Fabrega, S., & Pende, M. (2017) · The EMBO Journal · doi:10.15252/embj.201694966 · Cited by 49
The role of p38 MAPK pathway in p53 compromised state and telomere mediated DNA damage response
Roy, S., Roy, S., Rana, A., Akhter, Y., Hande, M. P., & Banerjee, B. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.05.018 · Cited by 48
CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment
Scheiblecker, L., Kollmann, K., & Sexl, V. (2020) · Pharmaceuticals · doi:10.3390/ph13120418 · Cited by 48
Watanabe, T., Tsuda, M., Tanaka, S., Ohba, Y., Kawaguchi, H., Majima, T., Sawa, H., & Minami, A. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0064 · Cited by 46
Sudbery, I. M., Enright, A. J., Fraser, A. G., & Dunham, I. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-175 · Cited by 46
Leong, S. Y., Ong, B. K. T., & Chu, J. J. H. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004686 · Cited by 45
Swanton, C., Larkin, J., Gerlinger, M., Eklund, A. C., Howell, M. T., Stamp, G., Downward, J., Gore, M. E., Futreal, P. A., Escudier, B. J., et al. (2010) · Genome Medicine · doi:10.1186/gm174 · Cited by 45
Self-citationYue, M., Luo, D., Yu, S., Liu, P., Zhou, Q., Hu, M., Liu, Y., Wang, S., Huang, Q., Niu, Y., et al. (2015) · Blood · doi:10.1182/blood-2015-07-659185 · Cited by 45
Priming of NLRP3 inflammasome activation by Msn kinase MINK1 in macrophages
Zhu, K., Jin, X., Chi, Z., Chen, S., Wu, S., Sloan, R. D., Lin, X., Neculai, D., Wang, D., Hu, H., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00761-1 · Cited by 46
MAP4K3 modulates cell death via the post-transcriptional regulation of BH3-only proteins
Lam, D., Dickens, D., Reid, E. B., Loh, S. H. Y., Moisoi, N., & Martins, L. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900608106 · Cited by 42
Silencing of STRN 4 suppresses the malignant characteristics of cancer cells
Wong, M., Hyodo, T., Asano, E., Funasaka, K., Miyahara, R., Hirooka, Y., Goto, H., Hamaguchi, M., & Senga, T. (2014) · Cancer Science · doi:10.1111/cas.12541 · Cited by 41
Multiplexing siRNAs to compress RNAi-based screen size in human cells
Martin, S. E., Jones, T. L., Thomas, C. L., Lorenzi, P. L., Nguyen, D. A., Runfola, T., Gunsior, M., Weinstein, J. N., Goldsmith, P. K., Lader, E., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm141 · Cited by 40
Melatonin antagonizes ovarian aging via YTHDF2-MAPK-NF-κB pathway
Zhu, R., Ji, X., Wu, X., Chen, J., Li, X., Jiang, H., Fu, H., Wang, H., Lin, Z., Tang, X., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.08.005 · Cited by 38
Gypenoside L Inhibits Proliferation of Liver and Esophageal Cancer Cells by Inducing Senescence
Ma, J., Hu, X., Liao, C., Xiao, H., Zhu, Q., Li, Y., Liu, Z., Tao, A., He, Z., Xu, C., et al. (2019) · Molecules · doi:10.3390/molecules24061054 · Cited by 33
High-throughput approaches to dissecting MAPK signaling pathways
Friedman, A. A., & Perrimon, N. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.002 · Cited by 33
A primer on using pooled shRNA libraries for functional genomic screens
Hu, G., & Luo, J. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr116 · Cited by 35
Wang, H., Song, X., Logsdon, C. D., Zhou, G., Evans, D. B., Abbruzzese, J. L., Hamilton, S. R., Tan, T., & Wang, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1751 · Cited by 32
Zhang, J., Lei, H., & Li, X. (2021) · Environmental Toxicology · doi:10.1002/tox.23361 · Cited by 31
Regulation of Tumorigenesis by p38α MAP Kinase
Dolado, I., & Nebreda, Á. R. (2007) · Springer eBooks · doi:10.1007/4735_2007_0245 · Cited by 31
Sasaki, T., Oga, T., Nakagaki, K., Sakai, K., Sumida, K., Hoshino, K., Miyawaki, I., Saito, K., Suto, F., & Ichinohe, N. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.024 · Cited by 29
Armeni, T., Ercolani, L., Urbanelli, L., Magini, A., Magherini, F., Pugnaloni, A., Piva, F., Modesti, A., Emiliani, C., & Principato, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052151 · Cited by 28
Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival
Ye, H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i21.6621 · Cited by 27
p38α limits the contribution of MAP17 to cancer progression in breast tumors
Guijarro, M. V., Vergel, M., Marín, J., Muñoz-Galván, S., Ferrer, I., y Cajal, S. R., Roncador, G., Blanco‐Aparicio, C., & Carnero, A. (2012) · Oncogene · doi:10.1038/onc.2011.619 · Cited by 27
Wang, Y., Cui, R., Zhang, X., Qiao, Y., Liu, X., Chang, Y.-F., Yu, Y., Sun, F., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7022 · Cited by 28
Basic Properties of the p38 Signaling Pathway in Response to Hyperosmotic Shock
Messaoud, N. B., Katzarova, I., & López, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135249 · Cited by 23
Dominguez‐Villar, M., Muñoz-Suano, A., Baz, B. A., Aguilar, S., Ruiz, J. P. N., Giron, J. A., Rodríguez‐Iglesias, M., & Garcia-Cozar, F. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507335 · Cited by 25
ERK1/2 and p38 cooperate to delay progression through G1 by promoting cyclin D1 protein turnover
Densham, R. M., Todd, D. E., Balmanno, K., & Cook, S. J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.07.005 · Cited by 22
Self-citationReactive Oxygen Species as Signaling Molecules
Rovira, I. I., & Finkel, T. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-420-9_16 · Cited by 19
Genes and pathways involved in senescence bypass identified by functional genetic screens
Roupakia, E., Markopoulos, G. S., & Kolettas, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111432 · Cited by 18
Xu, L., Wang, L., Yang, R., Li, T., & Zhu, X. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad052 · Cited by 17
Yu, D., Hu, J., Sheng, Z., Fu, G., Wang, Y., Chen, Y., Pan, Z., Zhang, X., Wu, Y., Sun, H. X., et al. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2019.09.009 · Cited by 16
Li, A. X., Martin, T. A., Lane, J., & Jiang, W. G. (2023) · Cancers · doi:10.3390/cancers16010076 · Cited by 15
Agonistic and Antagonistic Roles for TNIK and MINK in Non-Canonical and Canonical Wnt Signalling
Mikryukov, A. A., & Moss, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043330 · Cited by 15
Schouest, K. R., KURASAWA, Y., Furuta, T., Hisamoto, N., Matsumoto, K., & Schumacher, J. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007450 · Cited by 15
Age-dependent regulation of antioxidant genes by p38α MAPK in the liver
Pérez, S., Rius‐Pérez, S., Tormos, A. M., Finamor, I., Nebreda, Á. R., Taléns‐Visconti, R., & Sastre, J. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.017 · Cited by 15
The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis
Xu, G., Yang, Z., Ding, Y., Liu, Y., Zhang, L., Wang, B., Tang, M., Jing, T., Jiao, K., Xu, X., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01964-6 · Cited by 15
Berger, K. L., Barriga, F., Lace, M. J., Turek, L. P., Zamba, G., Domann, F. E., Lee, J. H., & Klingelhutz, A. J. (2006) · Virology · doi:10.1016/j.virol.2006.07.039 · Cited by 14
Jaśkiewicz, K., Maleszka-Kurpiel, M., Kabza, M., Karolak, J. A., & Gajęcka, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1197054 · Cited by 13
Bantle, C. M., French, C. T., Cummings, J. E., Sadasivan, S., Tran, K., Slayden, R. A., Smeyne, R. J., & Tjalkens, R. B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245171 · Cited by 13
Expanding the repertoire of RNA interference screens for developing new anticancer drug targets
Haney, S. A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1429 · Cited by 13
RNAi Applications in Target Validation
Kourtidis, A., Eifert, C., & Conklin, D. S. (2007) · Springer eBooks · doi:10.1007/978-3-540-31339-7_1 · Cited by 13
Ding, B., Li, J., Yan, J.-L., Jiang, C., Qian, L.-B., & Pan, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1515605 · Cited by 11
MAP4K signaling pathways in cancer: roles, mechanisms and therapeutic opportunities
Bunardi, C. S., Yeom, M., Kosasih, P., Han, H., Wang, W., & Seo, G. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01544-8 · Cited by 16
A defective splicing machinery promotes senescence through MDM4 alternative splicing
Deschênes, M., Durand, M., Olivier, M., Pellerin‐Viger, A., Rodier, F., & Chabot, B. (2024) · Aging Cell · doi:10.1111/acel.14301 · Cited by 9
Yeh, S., Chen, S., & Chen, B. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00117 · Cited by 10
TNIK: A redox sensor in endothelial cell permeability
Joachim, J., Maselli, D., Petsolari, E., Aman, J., Swiatlowska, P., Killock, D., Chaudhry, H., Zarban, A. A., Sarker, M. H., Fraser, P. A., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk6583 · Cited by 9
Wang, J., Song, L., Yang, S., Zhang, W., Lu, P., Li, S., Li, H., & Wang, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7131 · Cited by 9
Kot, A., Koszewska, D., Ochman, B., & Świętochowska, E. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46120826 · Cited by 9
Dokla, E. M. E., Mahmoud, A. H., Elsayed, M., El‐Khatib, A. H., Linscheid, M. W., & Abouzid, K. A. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049284 · Cited by 8
Zhao, C.-S., Huang, D., Peng, T., Huang, M., Xie, C., Chen, J., Kong, J.-R., Xie, R.-C., Liu, Y., & Wang, W. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2017.03.026 · Cited by 8
Long, X., Steurer, B., Wong, C. W., Kozlova, E., Naumov, V., Pun, F. W., Aliper, A., Ren, F., & Zhavoronkov, A. A. (2024) · Future Medicine AI · doi:10.2217/fmai-2023-0019 · Cited by 4
Cattani‐Cavalieri, I., Li, Y., Margolis, J., Bogard, A. S., Roosan, M. R., & Ostrom, R. S. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1149063 · Cited by 4
(2006) · Nature reviews. Cancer · doi:10.1038/nrc1791 · Cited by 4
Su, C., Johnson, M. E., Torres, A., Thomas, R. M., Manduchi, E., Sharma, P. K., Coz, C. L., Leonard, M. E., Lu, S., Hodge, K. M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.20.885426 · Cited by 3
Expression and functional validation of new p38α transcriptional targets in tumorigenesis
Swat, A., Dolado, I., Igea, A., Goméz-López, G., Pisano, D. G., Cuadrado, A., & Nebreda, Á. R. (2011) · Biochemical Journal · doi:10.1042/bj20101410 · Cited by 2
Drug target discovery using retroviruses
Blø, M., Micklem, D., & Lorens, J. B. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.10.1285 · Cited by 2
Induction of Cellular Senescence: Role of Mitogen-Activated Protein Kinase-Interacting Kinase 1
Ziaei, S., & Shimada, N. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_12 · Cited by 1
Design and Application of a shRNA-Based Gene Replacement Retrovirus
Zhang, R., Adams, P. D., & Ye, X. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-547-3_12 · Cited by 1
Oncogenic RAS Signalling Promotes Tumour Immunoresistance by Stabilising PD-L1 mRNA
Coelho, M. (2017) · UCL Discovery (University College London) · Cited by 1
Characterization of Efferosome Maturation and the Processing of Apoptotic Bodies
Kim, Y. (2014) · Scholarship@Western (Western University)
Costa, M. N. (2009) · UNM’s Digital Repository (University of New Mexico)
Analysis of senescence-like growth arrest induced by RUNX1 and its fusion derived oncoproteins
Wolyniec, K. (2008) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.578
Porquet, M. Z. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Oncogene-Induced Senescence (OIS) as a Cellular Response to Oncogenic Stresses
Bourdeau, V., & Ferbeyre, G. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1075-2_3
Metadata
- Authors
- Nicke, B., Bastien, J., Khanna, S. J., Warne, P. H., Cowling, V., Cook, S. J., Peters, G., Delpuech, O., Schulze, A., Berns, K., Mullenders, J., Beijersbergen, R. L., Bernards, R., Ganesan, T. S., Downward, J., & Hancock, D. C.
- Affiliations
- Cancer Research UK (GB)
- Babraham Institute (GB)
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Downward, Julian
- ORCID
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 20
- Issue
- 5
- Pages
- 673-685
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2067838259
- Cited by
- 108
- References
- 47
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 4 · 2021: 6 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 1 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 6
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- KWF Kankerbestrijding
- Biotechnology and Biological Sciences Research Council (BBS/E/B/0000C199, BBS/E/B/0000H457)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- mink, oncogenic Ras, ovarian surface epithelial cells, p21, growth arrest, p38 MAPK, RAF/ERK pathway, reactive oxygen species, senescence, oncogenic transformation, S6K1, cell cycle arrest
- MeSH terms
- Cell Cycle, Cell Transformation, Neoplastic, Epithelial Cells, Female, Humans, Ovarian Neoplasms, Phenotype, Signal Transduction, Proto-Oncogene Proteins p21(ras), Protein Serine-Threonine Kinases, Reactive Oxygen Species, MAP Kinase Kinase Kinases, Saccharomyces cerevisiae Proteins, RNA Interference, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, p38 Mitogen-Activated Protein Kinases, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review